https://sputnikglobe.com/20230109/new-zealand-to-vaccinate-people-against-mpox-with-unapproved-vaccine---reports-1106161787.html
New Zealand to Vaccinate People Against Mpox With Unapproved Vaccine, Report Says
New Zealand to Vaccinate People Against Mpox With Unapproved Vaccine, Report Says
Sputnik International
New Zealand authorities are preparing to vaccinate the population against mpox, also known as monkeypox, with a vaccine that has not yet been approved.
2023-01-09T11:28+0000
2023-01-09T11:28+0000
2023-01-09T11:33+0000
world
vaccinations
healthcare
monkeypox
https://cdn1.img.sputnikglobe.com/img/07e6/07/19/1097781625_0:192:2048:1344_1920x0_80_0_0_dabdea4d985b07238a9bdc7f44bdfb46.jpg
The authorities want to get a vaccine out as soon as possible, but Medsafe, New Zealand Medicines and Medical Devices Safety Authority has asked for necessary documentation from the manufacturer, which means that the vaccine will be rolled out unapproved, New Zealand's TV channel reported. Since it is against law to advertise unapproved medicines, there will be no big marketing campaign and the vaccine's proprietary name will not be used, media reported. In August 2022, media reports said the country's authorities are considering the use of the Jynneos mpox vaccine recommended in the United States, Australia and the United Kingdom. The report said only about 5,000 vials of the vaccine that is enough for immunization of nearly 20,000 people were so far obtained. The vaccine will be available from January 16. Mpox is a rare viral disease that is usually transmitted to people from wild animals and is endemic in some African countries. The disease usually results in fever, rash and swollen lymph nodes. Since May 2022, mpox cases have been reported from countries where the disease is not endemic. The decease affected over 83,000 people in 110 countries, including 66 fatalities, according to the latest data from the World Health Organization. New Zealand has registered 41 confirmed cases.
https://sputnikglobe.com/20220525/what-is-monkeypox-and-how-is-it-transmitted-1095774197.html
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2023
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
https://cdn1.img.sputnikglobe.com/img/07e6/07/19/1097781625_0:0:2048:1536_1920x0_80_0_0_828aaf7c63b5777793e8f939d1d083e5.jpgSputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
mpox in new zealand, mpox fatality rate, how mpox is spread, monkepox, vaccination against monkeypox, is there vaccine against monkepox
mpox in new zealand, mpox fatality rate, how mpox is spread, monkepox, vaccination against monkeypox, is there vaccine against monkepox
New Zealand to Vaccinate People Against Mpox With Unapproved Vaccine, Report Says
11:28 GMT 09.01.2023 (Updated: 11:33 GMT 09.01.2023) MOSCOW (Sputnik) - New Zealand authorities are preparing to vaccinate the population against mpox, also known as monkeypox, with a vaccine that has not yet been approved, local media reported on Monday.
The authorities want to get a vaccine out as soon as possible, but Medsafe, New Zealand Medicines and Medical Devices Safety Authority has asked for necessary documentation from the manufacturer, which means that the vaccine will be rolled out unapproved, New Zealand's TV channel reported.
Since it is against law to advertise unapproved medicines, there will be no big marketing campaign and the vaccine's proprietary name will not be used, media reported.
"That’s right, we can’t [promote or advertise unapproved medicines]. But we are making sure that everyone has the opportunity for a funded visit with their medical practitioner to discuss whether the vaccine is right for them," Associate Health Minister Ayesha Verrall stated.
In August 2022, media reports said the country's authorities are considering the use of the Jynneos mpox vaccine
recommended in the United States, Australia and the United Kingdom. The report said only about 5,000 vials of the vaccine that is enough for immunization of nearly 20,000 people were so far obtained. The vaccine will be available from January 16.
Mpox is a rare viral disease that is usually transmitted to people from wild animals and is endemic in some African countries. The disease usually results in fever, rash and swollen lymph nodes. Since May 2022, mpox cases have been reported from countries where the disease is not endemic. The decease affected over 83,000 people in 110 countries, including 66 fatalities, according to the latest data from the World Health Organization. New Zealand has registered 41 confirmed cases.